Matica Bio Partners With Calidi Bio To Advance Oncolytic Virus
03 Nov 2025 //
PR NEWSWIRE
Matica Bio Leads as Go-To CDMO for Cell & Gene Therapy in 2025
06 Oct 2025 //
PR NEWSWIRE
Matica Bio Lands Manufacturing Deal with U.S. Biotech Firm
15 Sep 2025 //
PR NEWSWIRE
Matica Biotech & Cirsium Launch AAV Manufacturing Collaboration
08 Sep 2025 //
PR NEWSWIRE
Matica Biotechnology, Texas A&M Partner to Support CGT Developers
05 May 2025 //
CONTRACTPHARMA
Treovir & Matica Bio Partner For Pediatric Brain Tumor Therapies
04 Dec 2024 //
BUSINESSWIRE
Matica Bio Names Min Park as Chief Commercial Officer
18 Nov 2024 //
CONTRACTPHARMA
Matica Bio`s Capsid Analysis Approach Transforms Viral Vector
05 Nov 2024 //
BUSINESSWIRE
Matica Biotechnology Establishes CDMO Partnership with KaliVir
24 Oct 2024 //
BUSINESSWIRE
Matica Bio Partners With Mongoose Bio For TCR-T Cell Therapy
16 Oct 2024 //
CONTRACTPHARMA
Matica Bio And CytoImmune Partner On Cell Therapy Program
10 Oct 2024 //
CONTRACTPHARMA
Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas
03 May 2022 //
BUSINESSWIRE

Market Place
Sourcing Support